HARTFORD HEALTHCARE HLS FUND is a registered fund series of HARTFORD SERIES FUND INC (series S000003206). Net assets $104.5M as of 2026-03-31.
Showing 15 of 86 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $12.6M | 1208.73% |
| Merck & Co Inc | — | $7.0M | 671.33% |
| Johnson & Johnson | — | $6.3M | 604.61% |
| UnitedHealth Group Inc | — | $4.3M | 411.38% |
| Intuitive Surgical Inc | — | $3.7M | 353.42% |
| AbbVie Inc | — | $3.3M | 318.70% |
| Abbott Laboratories | — | $3.0M | 288.22% |
| Danaher Corp | — | $3.0M | 283.62% |
| Edwards Lifesciences Corp | — | $2.9M | 273.02% |
| Vertex Pharmaceuticals Inc | — | $2.6M | 250.22% |
| Boston Scientific Corp | — | $2.3M | 221.42% |
| CVS Health Corp | — | $2.2M | 209.67% |
| Cencora Inc | — | $2.1M | 197.23% |
| Regeneron Pharmaceuticals Inc | — | $2.0M | 187.07% |
| HCA Healthcare Inc | — | $1.9M | 185.80% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $104.5M |
| 2025-12-31 | $115.4M |
| 2025-09-30 | $105.2M |
| 2025-06-30 | $104.8M |
| 2025-03-31 | $113.3M |
| 2024-12-31 | $117.6M |
| 2024-09-30 | $141.9M |
| 2024-06-30 | $138.6M |